Early Breast Cancer - Adjuvant Treatment
-
Breast Cancer
Early Breast Cancer - Adjuvant Treatment
-
Radiation
-
High Risk
-
Low Risk
-
-
HER2+
-
Stage 1
-
VICCBRE2241
PhII TPIV100/Placebo & Sargramostim for Tx of HER2+ Stage II-III BC in Pts w/Res Dis Aft Chemo/Surg
-
-
TNBC
-
>T1c any N
-
Adjuvant
-
VICC-NTBRE23357
De-Esc of Tx in Early-Stage TNBC Pts Who Achieve PCR After Neo-ADJ Chemo w/Checkpoint Inhibitor Tx
-
-pCR after neoadjuvant treatment/surgery
- Randomized to continuing pembrolizumab vs observation
-
-
VICC-DTBRE23439
MK2870+Pembrolizumab vs TPC in Pts w/TNBC Who Recevied NeoAdjvant Tx w/No pCR at Surgery
-
-patients with TNBC and residual disease who received Keynote-522.
-ER/PR must be 0 and patient must be able to get immunotherapy still
-They will receive Sac-TMT + pembro as adjuvant therapy
-
-
-
Any T, N1-3 or >T1c any N
-
-
ER+
-
VICC-DTBRE24171
Ph3 Study of Elacestrant in Node+ ER+ HER2- Early Breast Cancer with a High Risk of Recurrence
-
-